Further studies are needed to delineate the effect and precise mechanisms of the NLK/Nurr1 signaling pathway in PCa development and progression, and also to demonstrate the value of this pathway as a therapeutic target. The gene discussed is NR4A2; the disease is posterior cortical atrophy.